Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 1
1956 1
1957 5
1958 6
1959 1
1960 3
1961 4
1962 1
1963 3
1964 5
1965 5
1966 6
1967 5
1968 3
1969 2
1970 5
1971 2
1972 3
1973 3
1974 6
1975 6
1976 4
1977 2
1978 6
1979 4
1980 8
1981 5
1982 7
1983 6
1984 5
1985 9
1986 9
1987 10
1988 8
1989 14
1990 9
1991 13
1992 10
1993 11
1994 7
1995 9
1996 10
1997 11
1998 10
1999 11
2000 6
2001 11
2002 5
2003 8
2004 6
2005 6
2006 10
2007 7
2008 8
2009 5
2010 15
2011 16
2012 16
2013 23
2014 19
2015 21
2016 24
2017 23
2018 22
2019 35
2020 46
2021 31
2022 30
2023 30
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

659 results

Results by year

Filters applied: . Clear all
Page 1
Memorial for Nils Lycke.
Strober W, Holmgren J, Mowat A. Strober W, et al. Mucosal Immunol. 2023 Feb;16(1):1-2. doi: 10.1016/j.mucimm.2022.12.004. Epub 2023 Jan 10. Mucosal Immunol. 2023. PMID: 36634818 Free article. No abstract available.
Remembering Nils Lycke (1954-2022).
Wick MJ, Yrlid U. Wick MJ, et al. Scand J Immunol. 2023 Jan;97(1):e13240. doi: 10.1111/sji.13240. Scand J Immunol. 2023. PMID: 36533838 Free article. No abstract available.
Per Brandtzaeg: patron of mucosal immunology.
Sollid LM, Lycke N. Sollid LM, et al. Mucosal Immunol. 2017 Jan;10(1):1-4. doi: 10.1038/mi.2016.111. Mucosal Immunol. 2017. PMID: 28138161 Free article. No abstract available.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
Svenningsson A, Frisell T, Burman J, Salzer J, Fink K, Hallberg S, Hambraeus J, Axelsson M, Nimer FA, Sundström P, Gunnarsson M, Johansson R, Mellergård J, Rosenstein I, Ayad A, Sjöblom I, Risedal A, de Flon P, Gilland E, Lindeberg J, Shawket F, Piehl F, Lycke J. Svenningsson A, et al. Lancet Neurol. 2022 Aug;21(8):693-703. doi: 10.1016/S1474-4422(22)00209-5. Lancet Neurol. 2022. PMID: 35841908 Clinical Trial.
ADP-ribosylating enterotoxins as vaccine adjuvants.
Lycke N, Lebrero-Fernández C. Lycke N, et al. Curr Opin Pharmacol. 2018 Aug;41:42-51. doi: 10.1016/j.coph.2018.03.015. Epub 2018 May 22. Curr Opin Pharmacol. 2018. PMID: 29702466 Review.
The 18th Germinal Centre Meeting.
Lycke N, Mårtensson-Bopp L, Yrlid U, Bemark M. Lycke N, et al. Scand J Immunol. 2014 Sep;80(3):159-60. doi: 10.1111/sji.12219. Scand J Immunol. 2014. PMID: 25141929 Free article. No abstract available.
Mucosal Vaccine Development Based on Liposome Technology.
Bernasconi V, Norling K, Bally M, Höök F, Lycke NY. Bernasconi V, et al. J Immunol Res. 2016;2016:5482087. doi: 10.1155/2016/5482087. Epub 2016 Dec 29. J Immunol Res. 2016. PMID: 28127567 Free PMC article. Review.
659 results